person

Roser S. I. L.

Country
Spain
Department
Internal Medicine

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
19
Sites with multiple studies

Has run more than one trial at 19 of 132 partner sites.

Specializations

Oncology – Advanced Solid Tumors

The investigator leads studies on advanced solid tumors across a wide anatomical spectrum, emphasizing molecularly defined sub‑groups.

  • Estrogen Receptor‑Positive HER2‑Negative Breast Cancer
  • Non‑Small Cell Lung Cancer with KRAS G12C mutation
  • Metastatic Colorectal Cancer
  • Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
  • Renal Cell Carcinoma with MET alteration

All trials are conducted at Hospital Vall d’Hebron, integrating precision‑medicine approaches.

Hematologic Malignancies

Research activity includes high‑risk myeloid and lymphoid neoplasms, targeting disease‑specific genetic drivers.

  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Chronic Lymphocytic Leukemia
  • Mantle Cell Lymphoma
  • Multiple Myeloma

Therapeutic strategies explore novel agents and combination regimens within the internal medicine department.

Autoimmune & Inflammatory Disorders

Focused investigations address systemic autoimmunity and organ‑specific inflammatory conditions.

  • Systemic Lupus Erythematosus
  • Cutaneous Lupus Erythematosus
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Myasthenia Gravis

Clinical protocols evaluate targeted immunomodulation and biomarker‑guided therapy.

Respiratory & Infectious Diseases

Activities span chronic pulmonary disorders and challenging infectious entities.

  • Obstructive Sleep Apnea in obesity
  • Nontuberculous Mycobacterial lung infection
  • COVID‑19
  • Acute bacterial skin and skin‑structure infections
  • Bronchiectasis

Trials prioritize novel antimicrobial agents and airway‑targeted therapeutics.

Cardiovascular & Metabolic Conditions

Research encompasses atherosclerotic disease, heart failure, and metabolic risk factors.

  • Atherosclerotic Cardiovascular Disease
  • Heart Failure with reduced ejection fraction
  • Type 2 Diabetes Mellitus
  • Obesity
  • Hypertension

Investigations assess cardiovascular outcomes and metabolic control in high‑risk cohorts.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.